Compare Tractor Supply Co (TSCO) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tractor Supply Co vs Viatris Inc — how do they compare? Tractor Supply Co trades at $36.36 (market cap $18.39B), while Viatris Inc trades at $16.25 (market cap $18.69B). The key difference: Tractor Supply Co and Viatris Inc are close in size by market cap, and Viatris Inc pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| TSCO | VTRS | |
|---|---|---|
Market Cap | $18.39B | $18.69B |
Sector | Consumer Cyclical | Health |
52-Week High | $62.65 | $17.86 |
52-Week Low | $29.14 | $9.49 |
Enterprise Value | $24.70B | $30.80B |
Dividend Yield | 2.72% | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tractor Supply (TSCO) trades at $36.24, up 4.68% today, with a mixed technical picture showing bullish moving averages but overbought RSI levels. Fundamentally, the company reported $15.52B in 2025 revenue with a net margin of 6.42%, though recent quarters saw EPS misses. Valuation metrics include a P/E of 18.38 and ROE of 39.51%, indicating strong profitability but high price-to-book at 6.99. Recent news highlights CEO share purchases and dividend declarations amid a 2026 outlook cut due to weak demand.
The stock presents a cautious opportunity with solid fundamentals offset by near-term headwinds. Upside potential exists from digital growth and pet initiatives, but risks include discretionary spending pressure and cost inflation. Analysts are divided, with a $36.29 price target suggesting limited upside from current levels, requiring careful monitoring of holiday sales and margin trends.
Viatris (VTRS) trades at $16.33, up 0.31% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q2 2026 EPS of $0.69, exceeding expectations, and revenue growth of 5% year-over-year. However, negative net income margins and a high P/E ratio of 236.2 highlight profitability challenges. Recent developments include FDA approval for Gwyn Lo contraceptive patch and ongoing divestitures to sharpen focus.
Outlook remains mixed: operational improvements and dividend payments offer stability, but persistent net losses and high debt pose risks. Analyst consensus leans Hold (61.54%), reflecting cautious optimism amid execution uncertainties. Investment appeal hinges on successful margin recovery and debt management in a competitive generic drug market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
